Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study

Vilazodone is a selective serotonin reuptake inhibitor and a 5-HT(1A) receptor partial agonist that is approved for treatment of major depressive disorder in adults in the USA and Mexico. The efficacy, safety, and tolerability of vilazodone for generalized anxiety disorder (GAD) were investigated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gommoll, Carl, Forero, Giovanna, Mathews, Maju, Nunez, Rene, Tang, Xiongwen, Durgam, Suresh, Sambunaris, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593467/
https://www.ncbi.nlm.nih.gov/pubmed/26291335
http://dx.doi.org/10.1097/YIC.0000000000000096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593467/
https://www.ncbi.nlm.nih.gov/pubmed/26291335
http://dx.doi.org/10.1097/YIC.0000000000000096

Ejemplares similares